A
Apex Healthcare Bhd
KLSE:AHEALTH
Apex Healthcare Bhd
KLSE:AHEALTH
Price:
2.61
MYR
Market Closed
Market Cap:
1.9B
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
MY |
|
I
|
InCity Immobilien AG
XBER:IC8
|
DE |
|
PagSeguro Digital Ltd
NYSE:PAGS
|
BR |
Relative Value
The Relative Value of one AHEALTH stock under the Base Case scenario is 2.38 MYR. Compared to the current market price of 2.61 MYR, Apex Healthcare Bhd is Overvalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AHEALTH
Relative Value
Base Case
2.38
MYR
Overvaluation 9%
A
Multiples Across Competitors
AHEALTH Competitors Multiples
Apex Healthcare Bhd Competitors
Apex Healthcare Bhd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
1.9B MYR | 1.9 | 28.7 | 13 | 15.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
